FDA Approves Subcutaneous Injection of Leqembi, Offering New Convenience for Alzheimer’s Treatment
In a significant move for Alzheimer's disease care, the U.S. Food and Drug Administration (FDA) has approved a new, more convenient method of administering the drug lecanemab, known by its brand...